GPRC5A and pachyonychia congenita: GPRC5A is a potential oncogene in adenocarcinoma cells of the pancreatic duct, and knocking out GPRC5A can reduce the proliferation and migration ability of PC cell lines, as well as inhibit their chemoresistance to gemcitabine, oxaliplatin, and fluorouracil (23).